title: Question 1: does the use of ranitidine increase the risk of NEC in preterm infants?
authors.affiliation: Neonatal Unit, Homerton University Hospital NHS Trust, , London, UK.
authors.forename: Manigandan
authors.initials: M
authors.lastname: Chandrasekaran
authors.forename: Paul
authors.initials: P
authors.lastname: Fleming
mesh_terms: D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D020345:Enterocolitis, Necrotizing / Q000139:chemically induced*; D019317:Evidence-Based Medicine / Q000379:methods; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000139:chemically induced* / Q000188:drug therapy; D011899:Ranitidine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000897:Anti-Ulcer Agents; D011899:Ranitidine